Additional file 1 of INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies
- Resource Type
- Authors
- Tilburg, Cornelis M. Van; Witt, Ruth; Heiss, Melanie; Pajtler, Kristian W.; Plass, Christoph; Poschke, Isabel; Platten, Michael; Harting, Inga; Sedlaczek, Oliver; Freitag, Angelika; Meyrath, David; Taylor, Lenka; Gnana Prakash Balasubramanian; Jäger, Natalie; Pfaff, Elke; Jones, Barbara C.; Milde, Till; Pfister, Stefan M.; Jones, David T. W.; Kopp-Schneider, Annette; Witt, Olaf
- Source
- Subject
- Language
Additional file 1. Eligibility criteria